TY  - JOUR

T1  - The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation.

JO  - Health Technol Assess

UR  - http://eprints.whiterose.ac.uk/1803/

PY  - 2006/11/01

AU  - Pandor A

AU  - Eggington S

AU  - Paisley S

AU  - Tappenden P

AU  - Sutcliffe P

ED  - 

DO  - DOI: 10.3310/hta10410

VL  - 10

IS  - 41

SP  - iii

EP  - 185

Y2  - 2025/01/13

ER  -